Drugs for Cholangiocarcinoma (Bile Duct Cancer)

Table. Drugs Prescribed for Cholangiocarcinoma (Bile Duct Cancer)

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Imfinzi (durvalumab)
Drug company
• AstraZeneca
Indication
• Treatment, in combination with gemcitabine and cisplatin, of adults with locally advanced or metastatic BTC
Patient support services
• Imfinzi Co-Pay Savings Program
  844-275-2360
  
  AZ&Me Prescription Savings Program
  844-275-2360

Drug name (generic name)
• Lytgobi (futibatinib) Tablets
Drug company
• Taiho Oncology
Indication
• Treatment of adults with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements
Patient support services
• Taiho Oncology Patient Support Program
  844-824-4648

Drug name (generic name)
• Pemazyre (pemigatinib) Tablets
Drug company
• Incyte
Indication
• Treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma that is associated with an FGFR2 gene fusion or other rearrangements
Patient support services
• Pemazyre Savings Program
  855-452-5234
  
  Pemazyre Patient Assistance Program
  855-452-5234
  
  Pemazyre Temporary Access Program
  855-452-5234

Drug name (generic name)
• Tibsovo (ivosidenib) Tablets
Drug company
• Servier Pharmaceuticals
Indication
• Treatment of adults with previously treated locally advanced or metastatic cholangiocarcinoma and IDH1 mutation
Patient support services
• Tibsovo Co-Pay Program
  844-409-1141
  
  Patient Assistance Program
  844-409-1141